Skip to content

BILOBA HEVERLEE: what changed

What changed

BILOBA HEVERLEE

BE 0455.548.721
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€14,020
2024 · -€93,609+€107,630
Equity
-€30,617
2024 · -€44,637+€14,020
Cash
€16,456
2024 · €36,655-€20,199
Balance sheet total
€760,814
2024 · €1.0m-€263,845

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€215,844

    down €215,844 (-67.6%), from €319,371 to €103,528

    of which Contracts in progress: -€203,730

  • Receivables within one year -€29,913

    down €29,913 (-29.8%), from €100,417 to €70,505

    of which Trade receivables: -€18,969

  • Cash -€20,199

    down €20,199 (-55.1%), from €36,655 to €16,456

    mainly Other debts (-€124,935) and Trade debts (-€104,009)

Equity and liabilities
  • Other debts -€124,935

    down €124,935 (-51.9%), from €240,780 to €115,845

  • Trade debts -€104,009

    down €104,009 (-53.8%), from €193,400 to €89,391

  • Debts after one year -€61,632

    down €61,632 (-12.3%), from €501,783 to €440,150

  • Current portion of long-term debt +€16,670

    up €16,670 (+118%), from €14,183 to €30,853

  • Profit (loss) carried forward +€14,020

    up €14,020 (+12.2%), from -€114,465 to -€100,445

Income statement
  • Gross operating margin +€141,101

    up €141,101 (+1,622%), from €8,698 to €149,800

  • Depreciation +€24,123

    up €24,123 (+171%), from €14,147 to €38,271

  • Financial charges +€8,846

    up €8,846 (+41.6%), from €21,240 to €30,085

  • Staff costs +€1,860

    up €1,860 (+3.1%), from €60,674 to €62,534

  • Other operating charges -€1,768

    down €1,768 (-26.2%), from €6,738 to €4,970

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€93,609
Gross operating margin +€141,101
Staff costs -€1,860
Depreciation -€24,123
Other operating charges +€1,768
Financial income -€412
Financial charges -€8,846
Result 2025 €14,020
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€64,977
Investment -€40,213
Financing -€44,963
Cash 2024 €36,655
Net result for the year +€14,020
Depreciation +€38,271
Stocks and contracts +€215,844
Receivables within one year +€29,913
Deferred charges and accrued income -€167
Trade debts -€104,009
Tax, wage and social debts +€773
Other debts -€124,935
Accrued charges and deferred income -€4,732
Investment in fixed assets (net) -€40,213
Debts after one year -€61,632
Current portion of long-term debt +€16,670
Cash 2025 €16,456
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,024,659 €760,814 -€263,845 -25.7%
Fixed assets 21/28 €560,360 €562,303 +€1,943 +0.3%
Tangible fixed assets 22/27 €560,360 €562,303 +€1,943 +0.3%
Land and buildings 22 €333,619 €306,807 -€26,812 -8.0%
Plant, machinery and equipment 23 €220,820 €251,454 +€30,633 +13.9%
Furniture and vehicles 24 €5,920 €4,042 -€1,878 -31.7%
Current assets 29/58 €464,299 €198,511 -€265,788 -57.2%
Stocks and contracts in progress 3 €319,371 €103,528 -€215,844 -67.6%
Stocks 30/36 €115,641 €103,528 -€12,113 -10.5%
Contracts in progress 37 €203,730 €0 -€203,730 -100%
Amounts receivable within one year 40/41 €100,417 €70,505 -€29,913 -29.8%
Trade receivables 40 €86,946 €67,977 -€18,969 -21.8%
Other amounts receivable 41 €13,472 €2,528 -€10,944 -81.2%
Cash at bank and in hand 54/58 €36,655 €16,456 -€20,199 -55.1%
Deferred charges and accrued income 490/1 €7,855 €8,022 +€167 +2.1%
Total equity and liabilities 10/49 €1,024,659 €760,814 -€263,845 -25.7%
Equity 10/15 -€44,637 -€30,617 +€14,020 +31.4%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €51,236 €51,236 = 0.0%
Distributable reserves 133 €51,236 €51,236 = 0.0%
Profit (loss) carried forward 14 -€114,465 -€100,445 +€14,020 +12.2%
Amounts payable 17/49 €1,069,296 €791,430 -€277,866 -26.0%
Amounts payable after more than one year 17 €501,783 €440,150 -€61,632 -12.3%
Financial debts 170/4 €501,783 €440,150 -€61,632 -12.3%
Amounts payable within one year 42/48 €560,373 €348,872 -€211,501 -37.7%
Current portion of amounts payable after more than one year 42 €14,183 €30,853 +€16,670 +118%
Financial debts 43 €100,000 €100,000 = 0.0%
Credit institutions 430/8 €100,000 €100,000 = 0.0%
Trade debts 44 €193,400 €89,391 -€104,009 -53.8%
Suppliers 440/4 €193,400 €89,391 -€104,009 -53.8%
Taxes, remuneration and social security 45 €12,009 €12,783 +€773 +6.4%
Taxes 450/3 €132 €728 +€597 +453%
Remuneration and social security 454/9 €11,878 €12,054 +€177 +1.5%
Other amounts payable 47/48 €240,780 €115,845 -€124,935 -51.9%
Accrued charges and deferred income 492/3 €7,140 €2,408 -€4,732 -66.3%
Non-recurring operating income 76A €0 €76,365 +€76,365
Remuneration, social security and pensions 62 €60,674 €62,534 +€1,860 +3.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €14,147 €38,271 +€24,123 +171%
Other operating charges 640/8 €6,738 €4,970 -€1,768 -26.2%
Gross operating margin 9900 €8,698 €149,800 +€141,101 +1,622%
Operating profit (loss) 9901 -€72,862 €44,025 +€116,887
Financial income 75/76B €492 €81 -€412 -83.6%
Recurring financial income 75 €492 €81 -€412 -83.6%
Financial charges 65/66B €21,240 €30,085 +€8,846 +41.6%
Recurring financial charges 65 €21,240 €30,085 +€8,846 +41.6%
Profit (loss) for the period before taxes 9903 -€93,609 €14,020 +€107,630
Profit (loss) for the period 9904 -€93,609 €14,020 +€107,630
Profit (loss) for the period to be appropriated 9905 -€93,609 €14,020 +€107,630
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.